VERA

Vera Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 0/10
  • Momentum↑ 8/10
Vera Therapeutics sales and earnings growth
VERA Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -52.87%
  • FCF Y/Y↓ -74.72%
Vera Therapeutics gross and profit margin trends
VERA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -43.50%
Vera Therapeutics net debt vs free cash flow
VERA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.1
  • Interest coverage↓ -32.6

Vera Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗